gabapentin
NDC 68382-355, gabapentin, tablet, from Zydus Pharmaceuticals USA Inc..
- Product NDC
- 68382-355
- Status
- Listed
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203934
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68382-355 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GABAPENTIN450 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68382-355-01 | 68382035501 | 100 TABLET in 1 BOTTLE (68382-355-01) |
| 68382-355-14 | 68382035514 | 60 TABLET in 1 BOTTLE (68382-355-14) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3cfd04ab-e421-441f-a10e-e4dd1412974d
Use it
Look up 68382-355 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68382-355 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68382-355. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.